Anti-inflammatory and anti-fibrotic effects of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in TAA induced mouse model of liver injury and fibrosis

被引：0
|
作者：
Kim, J. [1 ]
Lee, J. [1 ]
Kim, Y. [1 ]
Lee, S. [1 ]
Kwon, H. [1 ]
Park, E. [1 ]
Choi, J. [1 ]
Bae, S. [1 ]
Kim, D. [1 ]
Lee, S. [1 ]
Choi, I. [1 ]
机构：
[1] Hanmi Phaarm Co Ltd, Seoul, South Korea
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
778
引用
收藏
页码：S400 / S401
页数：2
相关论文
共 50 条
  • [41] Potent Body Weight Loss and Efficacy in a NASH Animal Model by a Novel Long-Acting GLP-1/Glucagon/GIP Tri-Agonist (HM15211)
    Choi, In Young
    Lee, Jong Suk
    Kim, Jung Kuk
    Park, Young Jin
    Jung, Sungyoub
    Kim, Young Hoon
    Kwon, Se Chang
    DIABETES, 2017, 66 : A304 - A304
  • [42] Multitarget Engagement Effect of a Novel Long-Acting Glucagon/GIPIGLP-1 Triple Agonist (HM15211) in Animal Model of NASH
    Kim, Jung Kuk
    Lee, Jong Suk
    Kwon, Hyunjoo
    Park, Eunjin
    Lee, Jongsoo
    Bae, Sungmin
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2021, 70
  • [43] Potent body weight loss, and therapeutic efficacy in a NASH animal model by a novel long-acting GLP-1/Glucagon/GIPtri-agonist (HM15211)
    Choi, I.
    Lee, J.
    Kim, J.
    Park, Y.
    Lee, S.
    Kim, Y.
    Kwon, S. -C.
    DIABETOLOGIA, 2017, 60 : S50 - S50
  • [44] Novel Combination of a Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) and Once-Weekly Basal Insulin (HM12460a) Offers Improved Glucose Lowering and Weight Loss in a Diabetic Animal Model
    Kim, Jung Kuk
    Lee, Jong Suk
    Choi, Jaehyuk
    Jung, Sung Youb
    Lee, Sang Hyun
    Choi, In Young
    Kim, Sun Jin
    DIABETES, 2018, 67
  • [45] Therapeutic effect of a novel long-actingGLP-1/GIP/Glucagon triple agonist (HM15211) in CDHFD-induced NASH and fibrosis mice
    Choi, J.
    Jo, H.
    Kim, J.
    Kwon, H.
    Lee, J.
    Bae, S.
    Kim, D.
    Lee, S.
    Choi, I.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S64 - S64
  • [46] Anti-inflammatory and anti-fibrotic effects of icosabutate as mono- or combination therapy with a GLP-1 receptor agonist, a FXR agonist or an ACC inhibitor in a dietary mouse model of progressive fibrosis
    Fraser, David A.
    Nohr-Meldgaard, Jacob
    Skjaeret, Tore
    Veidal, Sanne
    Feigh, Michael
    Harrison, Stephen
    JOURNAL OF HEPATOLOGY, 2021, 75 : S622 - S623
  • [47] YH25724, a Novel Long-Acting GLP-1/FGF21 Dual Agonist, Exhibits Marked Anti-Fibrotic Effects in a Rat Model of Established Thioacetamide-Induced Liver Fibrosis
    Kim, Tae Wang
    Kim, Junhwan
    Hong, Han Na
    Choi, Hyun Ho
    Kim, Do-Hoon
    Yang, Ji-Eun
    Jeong, Da-Na
    Ju, Mi Kyeong
    Seo, Minji
    Kim, Su Kyung
    Park, Ju-Young
    Choi, Byung Hyun
    Kim, Han-Joo
    Ahn, Kyoung Kyu
    Kim, Jong Gyun
    Ratziu, Vlad
    Oh, Se-Woong
    Choi, Soongyu
    HEPATOLOGY, 2018, 68 : 434A - 435A
  • [48] YH25724, a novel long-acting GLP-1/FGF21 dual agonist, exhibits marked anti-fibrotic effects in different experimental models of liver fibrosis
    Kim, Dohoon
    Kim, Junhwan
    Kim, Tae Wang
    Hong, Han
    Choi, Hyun
    Yang, Ji-Eun
    Jeong, Da-Na
    Ju, Mi Kyeong
    Seo, Minji
    Kim, Su Kyung
    Park, Ju-Young
    Choi, Byung Hyun
    Kim, Han-Joo
    Ahn, Kyoung Kyu
    Kim, Jong-Gyun
    Bedossa, Pierre
    Ratziu, Vlad
    Oh, Se-Woong
    Choi, Soongyu
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E793 - E793
  • [49] A randomized, double-blinded, placebo-controlled single ascending dose study to assess safety, tolerability, immunogenicity, and pharmacokinetics of a novel long-acting GLP-1/GIP/glucagon triple agonist (hm15211) in healthy obese subjects
    Choi, JaeDuk
    Kim, Youngmin
    Eun, Kahee
    Morrow, Linda
    Hompesch, Marcus
    Baek, Seungjae
    JOURNAL OF HEPATOLOGY, 2020, 73 : S455 - S456
  • [50] Lipolytic and insulinotropic effects of HM12525A, a novel long-acting GLP-1/glucagon dual agonist
    Jung, S.
    Park, Y.
    Kim, J.
    Lee, J.
    Lee, Y. -M.
    Kim, Y.
    Kang, J.
    Trautmann, M.
    Hompesch, M.
    Kwon, S.
    DIABETOLOGIA, 2014, 57 : S352 - S352
12345